Biolife solutions to attend and present at upcoming investor conferences

Bothell, wash., march 1, 2022 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (cgt) and the broader biopharma markets, today announced mike rice, chairman and ceo, rod de greef, president and coo, and troy wichterman, cfo, are scheduled to present at both the cowen and keybanc investor conferences in march 2022.
BLFS Ratings Summary
BLFS Quant Ranking